Carlisle holder plans sale of 36,260 shares

Carlisle Companies has a planned stock sale disclosed in a Form 144 notice.

Accepted by SEC EDGAR 02/10/2026 - 05:44 PM EST Learn about SEC filing dates

Rhea-AI Filing Summary

Carlisle Companies has a planned stock sale disclosed in a Form 144 notice. A shareholder intends to sell up to 36,260 shares of common stock through UBS Financial Services on the NYSE, with an aggregate market value of $14,504,000. The shares were acquired by exercising stock options for cash on 02/10/2026. Shares outstanding were 42,500,000, providing context for the planned sale size.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the Form 144 filing for CSL disclose?

The Form 144 for CSL discloses a planned sale of 36,260 shares of Carlisle Companies common stock. The filing outlines the trade size, broker, market value, acquisition method, and the intended stock exchange for the sale.

How many Carlisle (CSL) shares are planned to be sold under this Form 144?

The notice covers a planned sale of 36,260 common shares of Carlisle Companies. This is the maximum amount indicated in the filing for the proposed transaction through the designated broker on the New York Stock Exchange.

What is the aggregate market value of the CSL shares in this Form 144?

The planned sale has an indicated aggregate market value of $14,504,000. This figure reflects the total market value of the 36,260 Carlisle Companies common shares referenced in the Form 144 notice.

How were the Carlisle (CSL) shares being sold acquired?

The 36,260 Carlisle shares in this Form 144 were acquired by stock option exercise. The filing states they were obtained from the issuer on 02/10/2026, with the exercise price paid in cash on the same date.

Which broker and exchange are involved in the CSL Form 144 sale?

The Form 144 lists UBS Financial Services Inc. as the broker, with an address in Weehawken, New Jersey. The planned sale of Carlisle Companies common stock is indicated to occur on the New York Stock Exchange (NYSE).

How many Carlisle (CSL) shares were outstanding when this Form 144 was filed?

The filing notes 42,500,000 shares outstanding of Carlisle Companies common stock. This number provides a reference point for understanding the relative size of the 36,260-share planned sale disclosed in the Form 144.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001190801
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	CARLISLE COMPANIES INC
SEC File Number	001-09278
Address of Issuer	16430 N. SCOTTSDALE RD., SUITE 400 Scottsdale ARIZONA 85254
Phone	480-781-5000
Name of Person for Whose Account the Securities are To Be Sold	Christian Koch
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	UBS Financial Services Inc 1000 Harbor Blvd 3rd Floor Weehawken NJ 07086	36260	14504000	42500000	02/10/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	02/10/2026	Options Exercise	Issuer			36260	02/10/2026	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks
Date of Notice	02/10/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/Mijo Suric, for UBS Financial Services Inc, as attorney-in-fact for Christian Koch
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)